Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid for chronic low back pain with Modic changes
2015-000751-25Phase 2Completed
- Sponsor
- Jaro Karppinen
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of zoledronic acid in chronic low back pain (CLBP) (2 arms), sponsored by Jaro Karppinen. Primary endpoint: Low back pain intensity. Started Dec 2015; status: completed.
02
Drugs
zoledronic acid
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on 2015-000751-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000751-25.